GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Drug Safety (Record no. 973)

MARC details
000 -LEADER
fixed length control field 01894nas a22002895i 4500
001 - CONTROL NUMBER
control field 1179-1942
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082442.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||sz uu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1179-1942
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/40264.1179-1942
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title Drug Saf
245 10 - TITLE STATEMENT
Title Drug Safety
Medium [electronic resource] :
Remainder of title The Official Journal of the International Society of Pharmacovigilance [ISoP] /
Statement of responsibility, etc. edited by Nitin Joshi.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Adis.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacovigilance.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Safety and Pharmacovigilance.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Joshi, Nitin.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 0114-5916
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/40264.1179-1942">https://doi.org/10.1007/40264.1179-1942</a>
Public note Hybrid

No items available.